Viking Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2017 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Viking Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2017 to Q2 2024.
  • Viking Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending June 30, 2024 was 110M shares, a 11.5% increase year-over-year.
  • Viking Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 94.3M shares, a 22.8% increase from 2022.
  • Viking Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 76.8M shares, a 0.47% decline from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 110M +11.4M +11.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-24
Q1 2024 103M +25.1M +32% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-25
Q4 2023 94.3M +17.5M +22.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-07
Q3 2023 99.8M +23.3M +30.5% Jul 1, 2023 Sep 30, 2023 10-Q 2023-10-25
Q2 2023 99M +22.2M +28.8% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-24
Q1 2023 78.4M +939K +1.21% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-25
Q4 2022 76.8M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-07
Q3 2022 76.5M -1.5M -1.93% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-25
Q2 2022 76.8M -1.05M -1.35% Apr 1, 2022 Jun 30, 2022 10-Q 2023-07-26
Q1 2022 77.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-04-26
Q3 2021 78M Jul 1, 2021 Sep 30, 2021 10-Q 2022-10-26
Q2 2021 77.9M Apr 1, 2021 Jun 30, 2021 10-Q 2022-07-27
Q1 2019 71.8M +27.1M +60.7% Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-02
Q3 2018 61.2M +33.8M +123% Jul 1, 2018 Sep 30, 2018 10-Q 2018-11-07
Q2 2018 52.8M +28.6M +119% Apr 1, 2018 Jun 30, 2018 10-Q 2018-08-09
Q1 2018 44.6M +22.3M +99.7% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-02
Q3 2017 27.5M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-07
Q2 2017 24.1M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 22.4M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.